Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The use of WEGOVY in patients with type 1 diabetes mellitus or in combination with insulin has not been evaluated
All of this is trial data, not a safety guarantee
For example, just 0.04% of people on semaglutide or tirzepatide developed NAION, compared with 0.02% of people on other diabetes medications
A post hoc analysis suggests that it has protective effects against this type of damage but they need further investigation for confirmation
We are a direct-pay practice, which means we do not bill insurance
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
